BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 9022454)

  • 1. Clinical effects of anticoagulants in suspected acute myocardial infarction. Use of anticoagulants in suspected acute myocardial infarction in Europe varies.
    Ketley D; Woods KL
    BMJ; 1997 Jan; 314(7075):223. PubMed ID: 9022454
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical effects of anticoagulants in suspected acute myocardial infarction. Adding heparin seems justified.
    James MA
    BMJ; 1997 Jan; 314(7075):222. PubMed ID: 9022452
    [No Abstract]   [Full Text] [Related]  

  • 3. Anticoagulants in acute MI.
    Santiago T; Chasuk R
    J Fam Pract; 1997 Jan; 44(1):28-9. PubMed ID: 9010364
    [No Abstract]   [Full Text] [Related]  

  • 4. [Antithrombotic agents in acute myocardial infarction].
    Boschat J; Larlet JM; Gilard M
    Arch Mal Coeur Vaiss; 1998 Apr; 91 Spec No 2():19-26. PubMed ID: 9749272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current status of antithrombotic agents in acute myocardial infarction.
    Khalilullah M; Sathyamurthy I
    J Assoc Physicians India; 1981 May; 29(5):351-7. PubMed ID: 7028713
    [No Abstract]   [Full Text] [Related]  

  • 6. Randomized comparison of a novel anticoagulant, vasoflux, and heparin as adjunctive therapy to streptokinase for acute myocardial infarction: results of the VITAL study (Vasoflux International Trial for Acute Myocardial Infarction Lysis).
    Peters RJ; Spickler W; Théroux P; White H; Gibson M; Molhoek PG; Anderson HV; Weitz JI; Hirsh J; Weaver WD
    Am Heart J; 2001 Aug; 142(2):237-43. PubMed ID: 11479461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical impact of local implementation of agreed guidelines for the management of patients with acute myocardial infarction.
    Badano L; Cassin M; Solinas L; Burelli C; Macor F; Zanuttini D
    G Ital Cardiol; 1999 Jan; 29(1):39-47. PubMed ID: 9987046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Functional features of acute non-Q-wave myocardial infarction and the influence of pre-hospital treatment with propranalol, heparin and aspirin on the prognosis of the disease].
    Beĭshenkulov MT; Kudaĭbergenova NT; Baltabaev TB
    Klin Med (Mosk); 2005; 83(1):28-32. PubMed ID: 15759487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Anticoagulation therapy in myocardial infarction (author's transl)].
    Bucher HJ
    Schweiz Rundsch Med Prax; 1975 Apr; 64(14):425-32. PubMed ID: 765994
    [No Abstract]   [Full Text] [Related]  

  • 10. [Initial heparin therapy and oral anticoagulants in acute myocardial infarct].
    Beck OA; Nunberger D; Hochrein H
    Med Welt; 1978 Feb; 29(6):232-6. PubMed ID: 622032
    [No Abstract]   [Full Text] [Related]  

  • 11. Prior aspirin users with acute non-ST-elevation coronary syndromes are at increased risk of cardiac events and benefit from enoxaparin.
    Santopinto J; Gurfinkel EP; Torres V; Marcos E; Bozovich GE; Mautner B; McCabe CH; Antman EM
    Am Heart J; 2001 Apr; 141(4):566-72. PubMed ID: 11275921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Heparin and acute myocardial infarct].
    Borchgrevink CF
    Tidsskr Nor Laegeforen; 1966 Sep; 86(18):1287-8. PubMed ID: 5915496
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical effects of anticoagulants in suspected acute myocardial infarction. Reduced intensity of anticoagulation may be indicated.
    Hood S; Birnie D
    BMJ; 1997 Jan; 314(7075):222; author reply 222-3. PubMed ID: 9022453
    [No Abstract]   [Full Text] [Related]  

  • 14. Anticoagulation in acute myocardial infarction.
    Barksdale C
    J Med Assoc State Ala; 1976 Nov; 6(5):28-32. PubMed ID: 1031435
    [No Abstract]   [Full Text] [Related]  

  • 15. [Platelet antiaggregants or anticoagulants in the secondary prevention after myocardial infarct].
    Di Pasquale G; Ottani F; Ceré E; Biancoli S; Sassone B; Lombardi A
    Recenti Prog Med; 1998 Oct; 89(10):514-9. PubMed ID: 9842255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparin, aspirin and beta-blockers in the acute myocardial infarction period.
    Cruickshank JM
    Therapie; 1992; 47(2):121. PubMed ID: 1357769
    [No Abstract]   [Full Text] [Related]  

  • 17. The role of heparin and aspirin during thrombolytic intervention in acute myocardial infarction.
    Heartbeat; 1990; 1(3):1-3. PubMed ID: 2078604
    [No Abstract]   [Full Text] [Related]  

  • 18. Rationale, design and organization of the Second Chinese Cardiac Study (CCS-2): a randomized trial of clopidogrel plus aspirin, and of metoprolol, among patients with suspected acute myocardial infarction. Second Chinese Cardiac Study (CCS-2) Collaborative Group.
    Second Chinese Cardiac Study (CCS-2) Collaborative Group
    J Cardiovasc Risk; 2000 Dec; 7(6):435-41. PubMed ID: 11189013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conduction disturbances and paroxysmal atrial fibrillation during acute inferior myocardial infarction.
    Patanè S; Marte F; Di Bella G; Chiribiri A
    Int J Cardiol; 2008 Sep; 129(2):e37-40. PubMed ID: 17689738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized comparison of enoxaparin with unfractionated heparin following fibrinolytic therapy for acute myocardial infarction.
    Baird SH; Menown IB; Mcbride SJ; Trouton TG; Wilson C
    Eur Heart J; 2002 Apr; 23(8):627-32. PubMed ID: 11969277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.